Expert Opinion on Emerging Drugs
Impact Factor & Key Scientometrics

Expert Opinion on Emerging Drugs
Overview

Impact Factor

4.191

H Index

51

Impact Factor

3.339

I. Basic Journal Info

Country

United Kingdom
Journal ISSN: 14728214, 17447623
Publisher: Taylor & Francis
History: 2000-ongoing
Journal Hompage: Link
How to Get Published:

Research Categories

Expert Opinion on Emerging Drugs
Impact Factor by Web of Science

Index

SCIE/SSCI

Impact Factor

4.191

by WOS

Ranking

2773

by WOS

Expert Opinion on Emerging Drugs
SJR, SJR Impact Factor and H Index

H Index

51

SJR

0.975

Scopus Impact Factor

3.339

Expert Opinion on Emerging Drugs
SJR Impact Factor 2-year, 3-year, 4-year

2-year
Impact Factor

3.339

3-year
Impact Factor

3.846

4-year
Impact Factor

3.339

Scope/Description:

Expert Opinion on Emerging Drugs ranks #60 of 216 in the Pharmacology & Pharmacy category in the 2008 ISI Journal Citation Reports. Expert Opinion on Emerging Drugs (ISSN 1472-8214 [print], 1744-7623 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing structured reviews on drugs/drug classes emerging onto the market across all therapy areas, providing expert opinion on their potential impact on the current management of specific diseases.

II. Science Citation Report (SCR)



Expert Opinion on Emerging Drugs
SCR Impact Factor

Expert Opinion on Emerging Drugs
SCR Journal Ranking

Expert Opinion on Emerging Drugs
SCImago SJR Rank

SCImago Journal Rank (SJR indicator) is a measure of scientific influence of scholarly journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from.

0.975

Expert Opinion on Emerging Drugs
Scopus 2-Year Impact Factor Trend

Note: impact factor data for reference only

Expert Opinion on Emerging Drugs
Scopus 3-Year Impact Factor Trend

Note: impact factor data for reference only

Expert Opinion on Emerging Drugs
Scopus 4-Year Impact Factor Trend

Note: impact factor data for reference only

Expert Opinion on Emerging Drugs
Impact Factor History

2-year 3-year 4-year
  • 2021 Impact Factor
    3.339 3.846 3.613
  • 2020 Impact Factor
    3.54 3.385 3.181
  • 2019 Impact Factor
    2.965 3.053 3.179
  • 2018 Impact Factor
    3 3.078 2.943
  • 2017 Impact Factor
    3.364 3.023 2.675
  • 2016 Impact Factor
    3.165 2.832 2.777
  • 2015 Impact Factor
    2.568 2.976 2.776
  • 2014 Impact Factor
    3.131 NA NA
  • 2013 Impact Factor
    3.416 NA NA
  • 2012 Impact Factor
    3.043 NA NA
  • 2011 Impact Factor
    3.935 NA NA
  • 2010 Impact Factor
    3.886 NA NA
  • 2009 Impact Factor
    3 NA NA
  • 2008 Impact Factor
    3.407 NA NA
  • 2007 Impact Factor
    3.02 NA NA
  • 2006 Impact Factor
    3.051 NA NA
  • 2005 Impact Factor
    2.794 NA NA
  • 2004 Impact Factor
    1.365 NA NA
  • 2003 Impact Factor
    0.5 NA NA
  • 2002 Impact Factor
    1.125 NA NA
  • 2001 Impact Factor
    0.889 NA NA
  • 2000 Impact Factor
    0.8 NA NA
Note: impact factor data for reference only

HIGHEST PAID JOBS

LATEX TUTORIALS

MUST-READ BOOKS


Impact Factor

Impact factor (IF) is a scientometric factor based on the yearly average number of citations on articles published by a particular journal in the last two years. A journal impact factor is frequently used as a proxy for the relative importance of a journal within its field. Find out more: What is a good impact factor?


III. Other Science Influence Indicators

Any impact factor or scientometric indicator alone will not give you the full picture of a science journal. There are also other factors such as H-Index, Self-Citation Ratio, SJR, SNIP, etc. Researchers may also consider the practical aspect of a journal such as publication fees, acceptance rate, review speed. (Learn More)

Expert Opinion on Emerging Drugs
H-Index

The h-index is an author-level metric that attempts to measure both the productivity and citation impact of the publications of a scientist or scholar. The index is based on the set of the scientist's most cited papers and the number of citations that they have received in other publications

51

Expert Opinion on Emerging Drugs
H-Index History